Article
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration.
Cancer biology & medicine - 8 Apr 2025
Feng Huijing, Xia Yang, Wang Wenxian, Xu Chunwei, Wang Qian, Song Zhengbo, Li Ziming, Yu Jinpu, Zhong Wenzhao, Wang Zhijie, Zhang Yongchang, Liu Jingjing, Zhang Shirong, Cai Xiuyu, Liu Anwen, Li Wen, Zhan Ping, Liu Hongbing, Lyu Tangfeng, Miao Liyun, Min Lingfeng, Lin Gen, Huang Long, Yuan Jingping, Jiang Zhansheng, Pu Xingxiang, Rao Chuangzhou, Lyu Dongqing, Yu Zongyang, Li Xiaoyan, Tang Chuanhao, Zhou Chengzhi, Mei Qi, Guo Hui, Chu Qian, Meng Rui, Liu Xuewen, Wu Jingxun, Zhou Jin, Zhu Zhengfei, Pan Weiwei, Pang Fei, Hu Meizhen, Wang Kai, Wu Fan, Xu Bingwei, Xu Ling, Wang Liping, Zhu Youcai, Li Jisheng, Xie Yanru, Lin Xinqing, Cai Jing, Wang Lin, Du Yingying, Yao Wang, Shi Xuefei, Niu Xiaomin, Yuan Dongmei, Yao Yanwen, Kang Jing, Zhang Jiatao, Zhang Chao, Gao Wenbin, Huang Jianhui, Zhang Yinbin, Sun Pingli, Wang Hong, Ye Mingxiang, Wang Dong, Wang Zhaofeng, Hao Yue, Wang Zheng, Wan Bing, Lyu Donglai, Jiao Xiaodong, Shi Lin, Lan Gang, Yang Shengjie, Shang Yanhong, Wang Yina, Li Bihui, Jin Gang, Zheng Kang, Ma Jun, Li Wenfeng, Zhang Zhang, Li Zhongwu, Li Yuan, Liu Zhefeng, Ma Xuelei, Yang Nong, Wu Lin, Wang Qiming, Wang Guansong, Hong Zhuan, Wang Jiandong, Fang Meiyu, Fang Yong, Zhu Xixu, Shen Yi, Wang Ke, Ren Xiubao, Zhang Yiping, Ma Shenglin, Zhang Junping, Song Yong, Fang Wenfeng, Lu Yuanzhi
Abstract excerpt
Alterations in the mesenchymal-epithelial transition factor (MET) gene are critical drivers of non-small cell lung cancer (NSCLC). In recent years advances in precision therapies targeting MET alterations have significantly expanded treatment options for NSCLC patients. These alterations include MET exon 14 skipping mutations (MET exon 14 skipping), MET gene amplifications, MET point mutations (primarily kinase...
Read the complete abstract on PubMed